AIM
AIM ImmunoTech
35 hedge funds and large institutions have $16.8M invested in AIM ImmunoTech in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
Holders
35
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.41M | |
| 2 | +$3.06M | |
| 3 | +$1.08M | |
| 4 |
BlackRock
New York
|
+$1.06M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$362K |
Top Sellers
| 1 | -$168K | |
| 2 | -$83.1K | |
| 3 | -$35K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$22K |
| 5 |
HF
HRT Financial
New York
|
-$20K |